Patent details

Basic Information

Publication number:

EP1658105

PCT Application Number:

US2004027539

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP047821012

PCT Publication Number:

WO2005023330

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL METERED DOSE INHALER AND METHODS RELATING THERETO

French Title of Invention:

AEROSOL-DOSEUR PHARMACEUTIQUE ET PROCEDES ASSOCIES

German Title of Invention:

PHARMAZEUTISCHER DOSIERINHALATOR UND RELEVANTE VERFAHREN

SPC Number:

Dates

Filing date:

25/08/2004

Grant date:

14/03/2018

EP Publication Date:

24/05/2006

PCT Publication Date:

17/03/2005

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

14/03/2018

EP B1 Publication Date:

14/03/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

25/08/2018

Expiration date:

25/08/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

07/03/2018

 

 

Name:

GLAXO GROUP LIMITED

Address:

980 Great West Road Brentford, Middlesex TW8 9GS, United Kingdom (GB)

Inventor

1

Name:

Sommerville, Mark L., GlaxoSmithKline

Address:

United States (US)

2

Name:

Miller, John F., GlaxoSmithKline

Address:

United States (US)

3

Name:

Schultz, Robert D., GlaxoSmithKline

Address:

United States (US)

Priority

Priority Number:

499250 P

Priority Date:

29/08/2003

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/12; B65D 83/00;

Publication

European Patent Bulletin

Issue number:

201811

Publication date:

14/03/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
31/12/2018	Outgoing Correspondence	1